NASDAQ · KRMD
KORU Medical Systems, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for KRMD: Nov 10, 2026
KORU Medical Systems, Inc. Common Stock (DE) is expected to report earnings on 11/10/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $0. The reported EPS for the same quarter last year was $-0.02.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.00 | $0.00 | $0.00 | 1 |
| Dec 2026 | $0.00 | $0.00 | $0.00 | 1 |
| Mar 2027 | $0.00 | $0.00 | $0.00 | 1 |
| Jun 2027 | $0.02 | $0.02 | $0.02 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · The Motley Fool · MarketBeat · RTTNews- Zacks · Oct 5, 11:06 AM EDTReasons to Retain Doximity Stock in Your Portfolio for NowDOCS' rapid clinical AI adoption and strong cash generation support its outlook, but tight pharma budgets and AI costs may limit near-term gains.
- The Motley Fool · Aug 12, 7:01 PM EDTKORU (KRMD) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 5, 10:04 PM EDTKORU Medical Systems Q2 Earnings Call HighlightsKORU Medical Systems (NASDAQ:KRMD) reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth. The company also said it achieved positive net income for the first time since
- Zacks · Aug 5, 6:10 PM EDTKORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat EstimatesKORU Medical Systems, Inc. (KRMD) delivered earnings and revenue surprises of +150.00% and +2.78%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · May 7, 9:57 AM EDTKORU Medical Systems Q1 Net Loss Narrows On Revenue Growth; Reaffirms FY26 Guidance; Stock Up(RTTNews) – KORU Medical Systems, Inc. (KRMD), a medical technology company, reported financial results for the first quarter ended March 31, 2026, with 22% revenue growth. In addition, the firm reiterated its full-year 2026 guidance.
- The Motley Fool · May 7, 9:17 AM EDTKoru Medical (KRMD) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 6, 6:30 PM EDTKORU Medical Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue EstimatesKORU Medical Systems, Inc. (KRMD) delivered earnings and revenue surprises of -33.33% and +3.56%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 5, 8:30 PM EDTAmerican Well Corporation (AMWL) Reports Q1 Loss, Tops Revenue EstimatesAmerican Well (AMWL) delivered earnings and revenue surprises of -1.30% and +9.23%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 4, 5:50 PM EDTInspire Medical Systems (INSP) Q1 Earnings and Revenues Top EstimatesInspire (INSP) delivered earnings and revenue surprises of +127.62% and +2.94%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Mar 20, 5:38 AM EDTPhreesia (PHR) Stock Jumps 5.1%: Will It Continue to Soar?Phreesia (PHR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
- The Motley Fool · Mar 17, 3:55 PM EDTKORU Medical (KRMD) Q4 2025 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · Mar 17, 11:36 AM EDTKORU Medical Secures EU MDR Certification for Freedom60 Infusion PumpKRMD secures EU MDR certification for its Freedom60 Infusion Pump, opening broader EU access and boosting adoption of patient-friendly home infusion solutions.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for KORU Medical Systems, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.